Buprelieve Injection M/Dose (CD Sch 3) 10ml
Zoetis Uk
Buprelieve Injection M/Dose (CD Sch 3) 10ml from ZOETIS UK LTD is supplied as a solution for injection.
LEGAL CLASSIFICATION:POM-V
THIS IS A SCHEDULE 3 CONTROLLED DRUG AND THEREFORE REQUIRES THE ORIGINAL PRESCRIPTION POSTING TO US.
To expedite screening and dispensing, please email a scan/photo of the signed prescription to mail@vets4u.uk first, then post the original signed paper prescription to our address. UK Controlled Drug regulations require us to hold the original on file.
We also require information about you and your Pet for us to be able to dispense your Pets medicine, please provide us with all your up to date information in the Question boxes below.
A link to the Medicine SPC on the VMD Product database can be found here: VMD Product Database
UK Public Assessment Report: UKPAR (PDF)
Post-Authorisation Assessment Report: PAAR (PDF)
Active Ingredient(s)
Buprenorphine
Pack & Presentation
Form: Solution for injection · Pack size: 10ML
Suitable Species
Cats, Dogs, Horses
Indications
Post-operative analgesia in the dog, cat and horse. Potentiation of the sedative effects of centrally-acting agents in the dog and horse. When used in horses, an intravenous sedative should be administered within five minutes prior to injection of buprenorphine.
Storage & Shelf Life
Do not store above 25ºC. Keep the vial in the outer carton in order to protect from light.
Owner Handling & Safety
Buprenorphine has opioid-like activity. Care should be taken to avoid self-injection. In case of accidental self-injection or ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
Contraindications & Warnings
Do not administer by the intrathecal or peridural route. Do not use pre-operatively for Caesarean section (see Section "Use during pregnancy, lactation or lay"). Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Use in Pregnancy & Lactation
Pregnancy: Laboratory studies in rats have not produced any evidence of a teratogenic effect. However, these studies have shown post-implantation losses and early foetal deaths.
Regulatory Information
- Legal category: POM-V
- Marketing authorisation holder: Zoetis UK Limited 1st Floor, Birchwood Building Springfield Drive Leatherhead Surrey KT22 7LP
- MA number: Vm 42058/5218
Important Notice
The information on this page is provided for general guidance only and does not replace the advice of a qualified veterinary surgeon. Always follow the directions provided on the product packaging and by your veterinary practice. If your animal's condition does not improve, worsens, or any side effects occur, contact your veterinary surgeon immediately.
